Canadian Journal of Diabetes

Do Provincial Formulary Restrictions Explain Differential Uptake of Sodium-Glucose Co-Transporter-2 Inhibitors in Adults with Diabetes and Cardiovascular Disease in Canada? A Retrospective Cohort Study of Pharmacy Claims


2 weeks 6 days ago

Ontario listed SGLT-2 inhibitors (SGLT2i) as regular public drug benefits for adults age ≥ 65, while other Canadian provinces providing benefits for SGLT2i implemented special authorization restrictions. We hypothesized that special authorization led to lower SGLT2i use among older adults with diabetes and cardiovascular disease (CVD) in other provinces (Alberta, Manitoba, New Brunswick, and Saskatchewan), compared to Ontario.
Darren Lau, Douglas C. Dover, Hena Qureshi, Roseanne O. Yeung, Dean Eurich, Peter Senior, Sonia Butalia, Padma Kaul

Impact of an Audit and Feedback-based Intervention on Preparation of Adolescents for Transition to Adult Type 1 Diabetes Care: A Multi-Center Quasi-Experimental Study


2 weeks 6 days ago

Adolescents and young adults (AYA) often report feeling poorly prepared and dissatisfied with the process of transitioning from pediatric to adult type 1 diabetes (T1D) care. We aimed to examine the impact of Bridging the Gap (BTG), an audit and feedback-based intervention, on transition care.
Syed Zain Ahmad, Noah Ivers, Ian Zenlea, Baiju R. Shah, Peter C. Austin, Cheril Clarson, Jennifer Harrington, Alanna Landry, Geetha Mukerji, Zubin Punthakee, Mark R. Palmert, Janet Parsons, Mikayla Sonnenberg, Rayzel Shulman

The association between insulin regimen and the risk of severe hypoglycemia and mortality in adults with type 2 diabetes. A large population based retrospective cohort study


4 weeks ago

To compare severe hypoglycemia and all-cause mortality between insulin regimens in people with type 2 diabetes on insulin.
Reid H. Whitlock, Zach Raizman, David Collister, Katherine J. Bernier, Sarah M. Sigurdson, Navdeep Tangri, Clara Bohm, Claudio Rigatto, Paul Komenda, Jennifer M. Yamamoto

Hypertension Treatment and Control in Canadians with Diabetes


1 month ago

We investigated hypertension control (<130/80 mmHg) among individuals with diabetes, use of first-line antihypertensive medications, and physician responses to uncontrolled blood pressure (BP) measurements (i.e. repeat measurements and medication intensification).
Sachin V. Pasricha, Lisa Dubrofsky, Bailey Goldman, Laura O’Driscoll, Huijuan Yang, Shane Golden, Brad Millson, Sheldon W. Tobe

“Beyond Glucose Control: A Critical Appraisal of Virtual vs. In-Person Care for Gestational Diabetes”


1 month 1 week ago

the article by Dolatabadi et al. offers timely insights into the use of virtual care in managing gestational diabetes mellitus (GDM), but several critical limitations temper the strength and applicability of its conclusions. This Letter to the Editor outlines concerns regarding the study’s retrospective design, its omission of patient-reported and adherence-related outcomes, and its limited generalizability. Drawing on recent literature, including evaluations aligned with the Quadruple Aim and meta-analyses of digital interventions, we argue for more robust and patient-centered methodologies in future research.
Muhammad Khubaib Iftikhar

Describing the experiences of healthcare providers who supported an outreach program to deliver point-of-care screening in adults with Type 1 and Type 2 diabetes who are experiencing homelessness in Calgary, Canada: A qualitative analysis.


1 month 1 week ago

Unstable housing and homelessness are associated with increased risks of diabetes-related morbidity and mortality. Concordantly, as few as 12-30% of people with lived experience of homelessness (PWLEH) complete recommended screening for microvascular complications of diabetes. Innovative models of care delivery are needed to address this disparity. We recently piloted a novel, community-based, point-of-care screening program for diabetes complications (the SAFER model of care, i.e. Screening for glycosylated hemoglobin (A1c), feet, eyes and renal function) in Calgary, Alberta.
Hannah M. Yaphe, Sara Scott, Huanghe Ding, Breanna McSweeney, Eshleen Grewal, David JT. Campbell

Addendum to “Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline” [Can J Diabetes. 2025;49:5–18]


2 months ago

The publisher regrets that Supplementary Material failed to be published with this article and is now included. The publisher apologizes for any inconvenience caused.
Ilana J. Halperin, Brandy Wicklow, Shazhan Amed, Alanna Chambers, Charlotte Courage, Elizabeth Cummings, Patricia Kirkland, Dylan MacKay, Meranda Nakhla, Zubin Punthakee, Paul M. Ryan, Lindsay Sawatsky, Peter A. Senior, Bikrampal S. Sidhu, Alanna Weisman…

Insomnia and Cardiometabolic Health: Bridging the Sleep Deficit to Disease Prevention


2 months ago

Insomnia a condition marked by difficulty initiating or maintaining sleep, or early morning awakenings despite an adequate opportunity for adequate rest. It affects up to one-third of adults, with around 10% meeting the criteria for insomnia disorder. Emerging research increasingly points to insomnia as a significant, modifiable risk factor for cardiometabolic diseases, including type 2 diabetes, cardiovascular disease, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease (MASLD).
J.W. Kim, A.B. Jain, A. Khullar

Virtual vs. In-Person Care in Gestational Diabetes Management: A Retrospective Cohort Analysis


2 months 1 week ago

The rising prevalence of gestational diabetes (GDM) presents a challenge to healthcare systems. Virtual care has emerged as a potential solution to alleviate this burden, but limited data exist on its effectiveness. This study evaluated maternal and neonatal outcomes in individuals with GDM managed with virtual care versus in-person care.
Samin Dolatabadi, Jennifer M. Yamamoto, Erin A. Brennand, Lois E. Donovan, Jamie L. Benham

Checked
2 hours 52 minutes ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed